Summary
The serum half-life of prostate-specific antigen (PSA) calculated subsequent to radical prostatectomy can serve to predict which patients are at high risk of bearing residual prostatic carcinoma despite their initial attainment of undetectable PSA serum levels. This report updates previous results to a mean follow-up period of 37 months. The initial results are essentially confirmed in that a mean PSA elimination half-life of 1.6 days in patients considered to be cured at least 24 months after prostatectomy provides additional useful information for predicting outcome in patients with potentially curable prostate cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Allhoff E, Riese W de, Eifinger M, Pethke J, Jonas U (1989) Prostate-specific antigen — comparative clinical appreciation of a serodiagnostic measure after 8 years of experience. World J Urol 7:12–16
Foster LS, Shinohara K, Carroll PR, Tanagho EA, Narayan P (1991) Residual prostate tissue as a cause for elevated PSA following radical prostatectomy. J Urol 145 [Suppl 4]:216A
Gleave ME, Hsieh JT, Wu HC, Eschenbach AC von, Chung LWK (1992) Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 52:1598–1605
Hudson MA, Bahnson RR, Catalona WJ (1989) Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142:1011–1017
Kleer E, Larson-Keller JJ, Zincke H, Oesterling JE (1993) Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Urology 41:207–216
Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R (1989) The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 141:873–879
Lightner DJ, Lange PH, Reddy PK, Moore L (1990) Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 144:921–926
Oesterling JE, Chan DW, Epstein JI, Kimball AW, Bruzek DJ, Rock RC, Brendler CB, Walsh PC (1988) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766–772
Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP (1993) Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor. J Urol 149:779–782
Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145:907–923
Pontes JE, Foemmel R, Jabalameli P, Howard PD, Montie J, Boyett J (1990) Prognostic implications of disappearance rate of biologic markers following radical prostatectomy. Urology 36:415–419
Schifman RB (1993) Prostate-specific antigen half-life. Lab Med Abstr Commun 3:2–3
Schifman RB, Ahmann FR, Elvick A, Ahmann M, Coulis K, Brawer MK (1987) Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 33:2086–2088
Schmid HP, McNeal JE, Stamey TA (1993) Observations on the doubling time of prostate cancer. Cancer 71:2031–2040
Semjonow A, Hamm M, Rathert P (1992) Half-life of prostate-specific antigen after radical prostatectomy: the decisive predictor of curative treatment? Eur Urol 21:200–205
Stamey TA, Yang N, Hay AR, McNeal JE, Feiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909–916
Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N (1989) Prostatic specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141:1076–1083
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Semjonow, A., Hamm, M. & Rathert, P. Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen. World J Urol 11, 218–220 (1993). https://doi.org/10.1007/BF00185073
Issue Date:
DOI: https://doi.org/10.1007/BF00185073